Discovery of Potent Antiallodynic Agents for Neuropathic Pain Targeting P2X3 Receptors

Title
Discovery of Potent Antiallodynic Agents for Neuropathic Pain Targeting P2X3 Receptors
Authors
배애님정용환김여옥Hai Lin조중희박진희이소덕배진수강근묵고효진박철승윤명하김용철Yoon-Gyoon Kim
Keywords
P2X3; neuropatic pain; antagonists
Issue Date
2017-07
Publisher
ACS Chemical Neuroscience
Citation
VOL 8, NO 7-1478
Abstract
Antagonism of the P2X3 receptor is one of the potential therapeutic strategies for the management of neuropathic pain because P2X3 receptors are predominantly localized on small to medium diameter C- and Aδ-fiber primary afferent neurons, which are related to the pain-sensing system. In this study, 5-hydroxy pyridine derivatives were designed, synthesized, and evaluated for their in vitro biological activities by two-electrode voltage clamp assay at hP2X3 receptors. Among the novel hP2X3 receptor antagonists, intrathecal treatment of compound 29 showed parallel efficacy with pregabalin (calcium channel modulator) and higher efficacy than AF353 (P2X3 receptor antagonist) in the evaluation of its antiallodynic effects in spinal nerve ligation rats. However, because compound 29 was inactive by intraperitoneal administration in neuropathic pain animal models due to low cell permeability, the corresponding methyl ester analogue, 28, which could be converted to compound 29 in vivo, was investigated as a prodrug concept. Intravenous injection of compound 28 resulted in potent antiallodynic effects, with ED50 values of 2.62 and 2.93 mg/kg in spinal nerve ligation and chemotherapy-induced peripheral neuropathy rats, respectively, indicating that new drug development targeting the P2X3 receptor could be promising for neuropathic pain, a disease with high unmet medical needs.
URI
http://pubs.kist.re.kr/handle/201004/66563
ISSN
1948-7193
Appears in Collections:
KIST Publication > Article
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE